Cabinet votes to leave historic Bute House agreement after government abandons emissions target
It follows the government's decision to scrap key climate targets and its response to a review into gender services.
Indivior had, in February, announced its intent to shift its listing by the middle of the year to the U.S., which, it argued, reflected its growth opportunities as its proprietary treatments are U.S.-centred and U.S.-based investors account for nearly 50% of its overall shareholder base. The list of UK-based companies that have already listed in the United States includes ARM, the UK's biggest chip company, as well as building supplies firm CRH and plumbing equipment company Ferguson. Indivior also reaffirmed its annual outlook after logging in a 12% net revenue growth in the first quarter, boosted by strong demand for its Sublocade treatment for opioid use disorder.